ATTO

15.1003.08%
AJ

Angie J. You

Independent Director

Dr. Angie J. You, Ph.D., is Director of NKGen Biotech Korea Co., Ltd. (formerly known as NKMAX CO., Ltd.) from August 14, 2025. Dr. You is Chief Executive Officer of Architect Therapeutics, Inc. Dr. You is Secretary & Director of Amunix Pharmaceuticals, Inc. from 2022. Since March 2023, Dr. You has served as Chief Executive Officer and member of the board of directors of Architect Therapeutics, LLC, a biotechnology company and since February 2022, Dr. You has served as a senior advisor to Frasier Healthcare. From April 2022 to May 2023, Dr. You served as advisor to Casdin Capital. Dr. You joined the Amunix Pharmaceuticals, Inc. in 2018. Dr. You was CEO, Secretary & Director of Amunix Pharmaceuticals, Inc. until 2022. Dr. You is Independent Director of ORIC Pharmaceuticals, Inc. from November 2021. Dr. You is Senior Advisor of Frazier Life Sciences Management, LP. Dr. You is Senior Advisor of Frazier Management, L.L.C. from February 2022. Dr. You joined the Frazier Management, L.L.C. in February 2022. Dr. You is Independent Director of Attovia Therapeutics, Inc. from July 2024. Dr. You is Director of Candid Therapeutics, Inc. from October 2024. Dr. You was Chief Business Officer of Aragon Pharmaceuticals, Inc. Dr. You was Chief Business & Strategy Officer and Head of Commercial of Sierra Oncology, Inc. from October 22, 2014 to December 2018. Dr. You was employed at Sierra Oncology, Inc. from October 22, 2014 to December 2018. Dr. You was Chief Business Officer of REN Pharmaceuticals, Inc. Dr. You was Advisor of Casdin Capital, LLC from 2022 to 2023. Dr. You was employed at Casdin Capital, LLC from April 2022 to May 2023. Dr. You was Independent Director of RayzeBio, Inc. from March 2022 to February 26, 2024. Dr. You was employed at RayzeBio, Inc. until February 26, 2024. Dr. You has Ph.D. in Biochemistry from Harvard University, B.A. in Chemistry from Harvard College.

Positions